Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells

Cancer Research

Volumn 57, Issue 14, 1997, Pages 2890-2895

  Mestre, Juan R ^b   Subbaramaiah, Kotha ^a   Sacks, Peter G ^b   Schantz, Stimson P ^b   Tanabe, Tadashi ^c   Inoue, Hiroyasu ^c   Dannenberg, Andrew J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; ISOTRETINOIN; MESSENGER RNA; PROSTAGLANDIN E2; RETINOIC ACID; RETINOID; RETINOL ACETATE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION;

CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MOUTH NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RETINOIDS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030747815     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Bennett, A., Charlier, E. M., McDonald, A. M., Simpson, J. S., Stamford, I. F., and Zebro, T. Prostaglandins and breast cancer. Lancet. 2: 624-626, 1977.
2. Jung, T. T. K., Berlinger, N. T., and Juhn, S. K. Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study. Laryngoscope, 95: 307-312, 1985.
3. Bennett, A., Carrol, M. A., Stamford, I. F., Whimster, W. F., and Williams, F. Prostaglandins and human lung carcinomas. Br. J. Cancer. 46: 888-893, 1982.
4. Rigas, B., Goldman, I. S., and Levine, L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 722: 518-523, 1993.
5. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
6. Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., and Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266: 12866-12872, 1991.
7. O'Banion, M. K., Sadowsky, H. B., Winn, V., and Young, D. A. A serum and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J. Biol. Chem., 266: 23261-23267, 1991.
8. DuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., and Bishop, P. R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest., 93: 493-498, 1994.
9. Rimarachin, J. A., Jacobson, J. A., Szabo, P., Maclouf, J., Creminon, C., and Weksler, B. B. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscl. Thromb., 14: 1021-1031, 1994.
10. Xie, W., Fletcher, B. S., Andersen, R. D., and Herschman, H. R. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol. Cell. Biol., 14: 6531-6539, 1994.
11. Subbaramaiah, K., Telang, N., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., and Dannenberg, A. J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 56: 4424-4429, 1996.
12. Kelley, D. J., Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., Ramonetti, J. T., and Dannenberg, A. J. Benzo(a)pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis (Lond.), 18: 795-799, 1997.
13. Inoue, H., Yokoyama, C., Hara, S., Tone, Y., and Tanabe, T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. J. Biol. Chem., 270: 24965-24971, 1995.
14. McCormick, D. L., and Moon, R. C. Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent. Br. J. Cancer, 48: 859-861, 1983.
15. Perkins, T. M., and Shklar, G. Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin. Oral Surg., 53: 170-178, 1982.
16. Rubio, C. A. Further studies on the therapeutic effect of indomethacin on esophageal tumors. Cancer (Phila.), 58: 1116-1119, 1986.
17. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55: 1464-1472, 1995.
18. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M., DeCosse, J. J., and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56: 2556-2560, 1996.
19. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantodosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. A. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
20. Δ716 knockout mice by inhibition of cyclooxygenase-2 (Cox-2). Cell, 87: 803-809, 1996.
21. Kelloff, G. J., Fay, J. R., Steele, V. E., Lubet, R. A., Boone, C. W., Crowell, J. A., and Sigman, C. C. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives. Cancer Epidemiol., Biomarkers & Prev., 5: 657-666, 1996.
22. Hamasaki, Y., Kitzler, J., Hardman, R., Nettesheim, P., and Eling, T. E. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch. Biochem. Biophys., 304: 226-234, 1993.
23. Moon, R. C., McCormick, D. L., and Mehta, R. G. Inhibition of carcinogenesis by retinoids. Cancer Res., 43: 2469s-2475s, 1983.
24. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
25. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
26. Sacks, P. G., Parnes, S. M., Gallick, G. E., Mansouri, Z., Lichtner, R., Satya-Prakash, K. L., Pathak, S., and Parsons, D. F. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res., 48: 2858-2866, 1988.
27. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randell, R. J. Protein measurement with the Polin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
28. Kameshita, I., and Fujisawa, H. A sensitive method for detection of calmodulin-dcpendent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem., 183: 139-143, 1989.
29. Gotoh, Y., Nishida, E., Matsuda, S., Shiina, N., Kosako, H., Shiokawa, K., Akiyama, T., Ohta, K., and Sakai, H. In vitro effects on microtubule dynamics of purified Xenopus M phase-activated MAP kinase. Nature (Lond.), 349: 251-254, 1991.
30. Laemmli, U. K. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
31. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
32. Habib, A., Creminon, C., Frobert, Y., Grassi, J., Pradelles, P., and Maclouf, J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J. Biol. Chem., 268: 23448-23454, 1993.
33. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
34. Rubin Grandis, J., and Tweardy, D. T. Elevated levels of transforming growth factor-α and epidermal growth factor messenger RNA as early markers of carcinogenesis in head and neck cancer. Cancer Res., 53: 3579-3584, 1993.
35. Shin, D. M., Ro, J. Y., Hong, W. K., and Hittelman, W. N. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54: 3153-3159, 1994.
36. Janot, F., Massaad, L., Ribrag, V., de Waziers, I., Beaune, P. H., Luboinski, B., Parise, O., Gouyette, A., and Chabot, G. G. Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma. Carcinogenesis (Lond.), 14: 1279-1283, 1993.
37. Guthrie, J., Robertson, I. G. C., Zeigler, E., Boyd, J. A., and Eling, T. Selective activation of some dihydrodiols of several polycyclic aromatic hydrocarbons to mutagenic products by prostaglandin synthetase. Cancer Res., 42: 1620-1623, 1982.
38. Eling, T. W., Thompson, D. C., Foureman, G. L., Curtis, J. F., and Hughes, M. F. Prostaglandin H synthase and xenobiotic oxidation. Annu. Rev. Pharmacol. Toxicol., 30: 1-45, 1990.
39. Denissenko, M. F., Pao, A., Tang, M-S., and Pfeifer, G. P. Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in p53. Science (Washington DC), 274: 430-432, 1996.
40. Goodwin, J. S., and Ceuppens, J. Regulation of the immune response by prostaglandins. J. Clin. Immunol., 3: 295-314, 1983.
41. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
42. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA. 93: 4816-4820, 1996.
43. Rubin Grandis, J., Zeng, Q., and Tweardy, D. J. Retinoic acid normalizes the increased gene transcription rate of TGF-α and EGFR in head and neck cancer cell lines. Nat. Med., 2: 237-240, 1996.
44. Sacks, P. G., Oke, V., Amos, B., Vasey, T., and Lotan, R. Modulation of growth, differentiation and glycoprotein synthesis by β-all-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int. J. Cancer, 44: 926-933, 1989.
45. Oridate, N., Lotan, D., Xu, X-C., Hong, W. K., and Lotan, R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 2: 855-863, 1996.
46. Lu, X., Xie, W., Reed, D., Bradshaw, W. S., and Simmons, D. L. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenase in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 7961-7965, 1995.
47. Weitzman, S. A., and Gordon, L. I. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood, 76: 655-663, 1990.
48. Zheng, Z. S., Xue, G. Z., and Pryslowsky, J. H. Regulation of the induction of omithine decarboxylase in keratinocytes by retinoids. Biochem. J., 309: 159-165, 1995.
49. Xie, W., and Herschman, H. R. v-src induces prostaglandin synthase 2 gene expression by activation of c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Chem., 270: 27622-27628, 1995.
50. Zou, C-P., Clifford, J. L., Xu, X-C., Sacks, P. G., Chambon, P., Hong, W. K., and Lotan, R. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res., 54: 5479-5487, 1994.
51. Schule, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L. J., Bolado, J., Verma, I. M., and Evans, R. M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA, 88: 6092-6096, 1991.
52. Salbert, G., Fanjul, A., Piedrafita, F. J., Lu, X. P., Kim, S- J., Tran, P., and Pfahl, M. Retinoic acid receptors and retinoid X receptor-α downregulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity. Mol. Endocrinol., 7: 1347-1356, 1993.
53. Oridate, N., Esumi, N., Lotan, D., Ki Hong, W., Rochette-Egly, C., Chambon, P., and Lotan, R. Implication of retinoic acid receptor γ in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells. Oncogene. 12: 2019-2028, 1996.
54. Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., and Dannenberg, A. I. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. Cancer Res., 57: 1081-1085, 1997.
55. Fanjul, A., Dawson, M. L. Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X-P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond.), 372: 107-111, 1994.